|
|
||||||||
Integrative Muscle Biology Laboratory, Exercise Science Department, University of South Carolina, Columbia, South Carolina 29208
| |
ABSTRACT |
|---|
|
|
|---|
This study's purpose was to examine whether functional overload with nandrolone decanoate (ND) administration increased muscle mass and steroid receptor concentration in aged rat soleus (Sol) and plantaris (Plan) muscle. ND (6 mg/kg body wt) was administered once a week for 4 wk, whereas control rats received sesame seed oil injections. Functional overload of the hindlimb Sol and Plan was induced by synergistic gastrocnemius muscle ablation at the beginning of the fourth week. Adult (5 mo of age) and aged rats (25 mo of age) were randomly assigned to four groups: control, overload, control-ND, and overload-ND. Seven days of functional overload increased adult Sol muscle mass 27%, whereas the aged Sol muscle mass did not change. The aged overloaded Sol muscle receiving ND significantly increased muscle weight by 35% and total muscle protein by 24%. Aged Plan muscle did not increase muscle weight with overload or ND treatment. Androgen receptor protein was induced by ND treatment and functional Ov, and combining the two treatments induced Sol androgen receptor protein concentration above either alone. Sol glucocorticoid receptor protein concentration increased in overload groups of both ages. ND administration can increase aged Sol muscle mass and protein content after 7 days of functional overload, and the cooperative induction of androgen receptor may be important for this response.
steroid receptor; hypertrophy; nandrolone decanoate; sarcopenia; muscle wasting
| |
INTRODUCTION |
|---|
|
|
|---|
AGING RESULTS IN A
PROGRESSIVE decrease in muscle strength, which can in part be
attributed to muscle mass loss (31). Skeletal muscle is primarily composed of highly oxidative, postmitotic fibers,
which undergo constant remodeling, and aging can induce an imbalance
within this remodeling process (29). Age-induced muscle
mass loss is associated with decreased muscle protein synthesis, muscle
fiber loss,
-motoneuron loss, and a decline in fiber cross-sectional area (35). Although skeletal muscle is a dynamic
tissue, aging decreases its plasticity to many stimuli, and this is
especially true of stimuli requiring muscle regeneration or remodeling
(5, 8, 14, 30). There is strong evidence that age-induced
decreases in muscle regenerative capacity are not intrinsic to the
muscle itself but rather are dependent on the aging organism as a whole (9, 22). Systemic-related changes with aging include
alteration in cardiovascular, endocrine, and immune systems
(31). Signaling stimuli targeting muscle may be deficient
in the aged organism; therefore, aged muscle's regenerative capacity
could possibly be restored if provided the appropriate stimuli.
Functional work overload of rat hindlimb muscle induces a rapid remodeling response, which includes structural damage, fiber growth, satellite cell activation, and macrophage infiltration (10, 16, 28, 41). Each of these responses has been hypothesized to be an important component for the large increases in muscle mass and protein content induced by functional overload. Aging alters rat hindlimb muscle growth induced by functional overload. Plantaris (Plan) muscle from 36-mo-old rats does not adapt to 8 wk of functional overload in the same manner as muscles from young rats. However, the response of aged rat hindlimb muscle during the onset of functional overload has not been determined.
Anabolic steroids are structural derivatives of testosterone, which can increase skeletal muscle mass and protein synthesis in adult and aged individuals (3, 38, 47). Exogenous testosterone administration with muscle loading can synergistically increase skeletal muscle mass in healthy and diseased humans (4). A synergistic relationship between testosterone and muscle loading is present in functionally overloaded rat muscle subject to disuse atrophy (45). Anabolic steroid administration can also abolish unloaded atrophy in the rat quadriceps muscle (48). Although anabolic steroids are a potent skeletal muscle mass effector, the intracellular signaling mechanisms induced by the interaction of overload and anabolic steroids have not been demonstrated.
Steroid receptors, a subgroup of the nuclear receptor superfamily, are transcription factors showing high homology in their DNA-binding domain (44). The androgen receptor and glucocorticoid receptor are both potential modulators of skeletal muscle mass. These receptors can alter cellular gene expression by binding ligand in the cytosol, translocating to the nucleus, and binding to their corresponding DNA response element to alter gene transcription (33, 44). Steroid receptors have also been shown to have ligand-independent effects on cellular gene expression, which can be modulated by several signaling pathways (25). Targets of androgen and glucocorticoid receptor-induced transcriptional activity related to skeletal muscle mass regulation have not been well characterized. The expression of the skeletal muscle androgen receptor is sensitive to circulating hormone levels, age of the animal, and muscle loading conditions. In humans, the skeletal muscle androgen receptor is downregulated after puberty (36), and androgen receptor levels are also decreased in 25-mo-old Fischer 344 × Brown Norway rat soleus (Sol) muscles compared with 5-mo-old animals (12). This change in androgen receptor concentration coincides with a dramatic reduction in circulating testosterone levels in Fischer 344 × Brown Norway rats between 4 and 28 mo of age (15). Skeletal muscle androgen receptor protein expression increases in aged men administered a physiological dose of testosterone for 1 mo (18). Rat Sol and Plan androgen receptor concentrations are induced by anabolic steroid administration in both young and old rats (12). Androgen receptor ligand binding capacity in rat skeletal muscle increases in functionally overloaded muscle (6, 23). However, the androgen receptor expression induction during overload induced muscle growth in aged rats is not known.
To our knowledge, the interaction between anabolic steroid administration and functional overload in aged rat hindlimb muscle has not been examined previously. The purpose of this study was to examine whether functional overload with nandrolone decanoate pretreatment increases muscle mass and steroid receptor concentration in aged rat Sol and Plan muscles. It was hypothesized that aging would attenuate muscle mass increases and androgen receptor protein induction after 7 days of functional overload. We also hypothesized that nandrolone decanoate pretreatment would interact with functional overload to increase muscle mass and steroid receptor concentration in aged skeletal muscle. The effects of synergist ablation-induced functional overload and nandrolone decanoate treatments on muscle mass, total DNA, total RNA, protein concentration, and steroid receptor protein concentration were examined in 5- and 25-mo-old Fischer 344 × Brown Norway rats.
| |
METHODS |
|---|
|
|
|---|
Animals and housing. Forty-three male Fisher 344 × F1 Brown Norway rats were acquired from the National Institutes on Aging aged rodent colony. Twenty rats were ~4 mo at the start of the study, and twenty-three rats were ~24 mo at the start of the study. Animals were housed individually, kept on a 12:12-h light-dark cycle, and given ad libitum access to normal rodent chow and water for the duration of the study at the fully accredited animal care facilities at the University of South Carolina, Columbia. Rats were randomly assigned to four treatment groups as follow: 1) control-oil (Con), 2) overload-oil (Ov), 3) control-steroid (Con-S), 4) overload-steroid (Ov-S). All procedures were approved by the University of South Carolina Animal Care and use Committee. A subset of the animals in the study was used in a study examining differences due to age. Data regarding a subset of control-oil and control-steroid treatment groups have been published elsewhere (12). As stated in the present study's purpose statement, the emphasis of this study is on interactions between functional overload and nandrolone decanoate pretreatment.
Anabolic steroid administration. The anabolic steroid nandrolone decanoate (Deca-Durabolin, Oranon) was used in these studies because of its long biological half-life and because previous studies have demonstrated an anabolic effect in rat skeletal muscle (12). The selected dose of nandrolone decanoate administration has been previously demonstrated to prevent hindlimb suspension-induced rat skeletal muscle atrophy (48). Nandrolone decanoate was injected (6 mg/kg body wt) intramuscularly into the hip region every 7 days, and the right and left hip region alternated each week. Control animals received a similar volume intramuscular injection of sesame seed oil. Each animal received four injections of either nandrolone decanoate in sesame seed oil or sesame seed oil alone. Sham or synergist ablation surgeries were performed after the third week of nandrolone decanoate treatment, and the fourth injection was given at the time of surgery.
Surgical ablation of synergists.
The hindlimb Sol and Plan muscles were functionally overloaded for 7 days by surgical ablation of the distal third of the lateral and medial
gastrocnemius muscle as previously reported (13).
Rats were anesthetized with an intramuscular injection of a cocktail
containing ketamine hydrocholoride (75 mg/kg body wt), xylazine (3 mg/kg body wt), and acepromazine (5 mg/kg body wt). In a sterile
aseptic environment, the dorsal surface of the hindlimb was shaved and
cleaned, and the gastrocnemius muscles were then exposed by a posterior
longitudinal incision through the skin and bicep femoris muscle of each
lower hindlimb, and the distal two-thirds of heads of each
gastrocnemius muscle were excised. The nerve and vasculature supplies
to the remaining musculature were undisturbed. Control animals
underwent sham surgeries, which consisted of the same procedure, except
for gastrocnemius excision. Incisions were closed by using wound clips,
with no postoperative complications being observed over the course of
the study. After the rats recovered from the anesthetic, they were
returned to their cages. Rats were weighed weekly and observed for
signs of failure to thrive, such as precipitous weight loss,
disinterest in the environment, or unexpected gait alterations. Sol and
Plan muscles were removed at 7 days after the initial surgery, frozen in liquid nitrogen, and stored at
80°C until further analysis.
Total DNA. Total muscle DNA was quantified as previously described (12). Briefly, a frozen Sol or Plan muscle (~25-50 mg) was cut and weighed. This same piece of muscle was then used to quantify total DNA, total RNA, and total protein. Muscle was homogenized in 0.2 N HClO4 and centrifuged (4°C, 12,000 g for 10 min). After several washes, the pellet was resuspended in 0.3 N KOH. At this stage, an aliquot was removed for total protein (see Total protein) and 0.75 vol of 1.2 N HClO4 was then added to the supernatant. After centrifugation (4°C, 12,000 g for 10 min), the supernatant was transferred to a new tube, and the pellet was washed two more times with 1.2 N HClO4. The supernatants from all washes combined for total RNA concentration. The pellet was resuspended in 1 M NaOH and incubated for 30 min at 50°C. DNA content was determined by a standard fluorimetric assay using bis-benzimide and salmon sperm DNA standards. DNA is expressed as the concentration per milligrams of muscle and as total DNA per whole muscle.
Total RNA. Total muscle RNA was quantified as previously described (12). Briefly, after initial homogenization centrifugation (see DNA assay), the pellet was washed two times with 1.2 N HClO4, the supernatants from all washes were combined, and the RNA was quantified by UV absorbance at 260 nm. Total RNA is expressed as the concentration per milligrams of muscle and as total RNA per whole muscle.
Total protein. Total muscle protein was quantified as previously described (14). Briefly, an aliquot of muscle homogenate (see DNA assay) was analyzed for protein content by the standard Bradford assay (Bio-Rad). Total protein is expressed as the concentration per milligram of muscle and as total protein per whole muscle.
Crude protein extracts.
Crude protein extracts were made as previously described (12, 19,
20). Frozen Sol and Plan muscles were homogenized in Mueller
buffer (50 mM HEPES, pH 7.4, 0.1% Triton X-100, 4 mM EGTA, 10 mM EDTA,
15 mM Na4P2O7, 100 mM
-glycerolphosphate, 25 mM NaF, 1 mM Na3VO4,
0.5 µg/ml leupeptin, 0.5 µg/ml pepstatin, and 0.3 µg/ml
aprotinin), 2 ml per 1 g of tissue. Tissue was homogenized on ice
with a Polytron homogenizer (Kinematica Switzerland) by using three
15-s pulses at a low setting. Homogenates were fractionated into
soluble and insoluble fractions by centrifugation, and the protein
concentration was determined by DC Lowrey assay (Bio-Rad) and aliquoted
at
80°C until use for Western blotting.
Western blot analysis. Western blot analysis was performed as previously reported (11). Forty micrograms of crude homogenate protein (40 µg) were incubated (15 min, 65°C) with an equal volume of protein sample buffer and fractionated on a 8% SDS-polyacrylamide gel (150 V, 25°C, 1 h), and electrophoretically transferred to a nitrocellulose membrane (300 mA, 4°C, 14 h). Transfer was verified by Ponceau S staining. Dose-response analysis of the androgen receptor and glucocorticoid receptor demonstrated that 40 µg of crude protein extract gave a signal in a linear range for quantification (data not shown). The membrane was then probed with either androgen receptor (N-20, Santa Cruz Biotechnology, Santa Cruz, CA) or glucocorticoid receptor (M-20, Santa Cruz Biotechnology) and polyclonal rabbit antibodies as previously described (16). The donkey anti-rabbit IgG horseradish peroxidase-linked secondary antibody was visualized by enhanced chemiluminescence (Amersham Life Sciences) as per manufacturer's instructions and quantified by densitometry scanning.
Data analysis.
Results are reported as means ± SE. For each age group, all
variables were analyzed by a two-way ANOVA analysis (steroid
treatment × functional overload) for each variable to determine
significant effects and interactions (P
0.05). When a
significant main effect of overload was found without any significant
effect of steroid treatment or any steroid × overload interaction,
data were presented as the pooled sham controls (oil and steroid) vs.
the pooled 7-day overload (oil and steroid). This was also done if the
main effect was steroid treatment. Post hoc analysis on significant
interactions was done with a Bonferroni test (P
0.05).
| |
RESULTS |
|---|
|
|
|---|
Body weight, muscle mass, and protein concentration.
Body weight was not affected by nandrolone decanoate or functional
overload in adult animal. There was a significant 6% decrease (P = 0.041) in body weight in aged animal (566 ± 11 vs. 530 ± 11 mg/kg). In adult animals, there was no
effect of nandrolone decanoate treatment on Sol and Plan muscle weight.
However, across both ND and oil treatment, there was a significant 27%
(P = 0.0025) and 14% (P = 0.01)
increase in Sol and Plan muscle weight in the overloaded group
(155 ± 6 vs. 196 ± 9 and 371 ± 12 vs. 423 ± 17 mg, respectively; Fig. 1). Aged Sol
muscle wet weight was not increased after 7 days of functional
overload, although adult Sol muscle mass increased. However, aged Sol
muscle from rats receiving nandrolone decanoate and functional overload
treatments increased muscle weight by 35% (P = 0.0024;
Fig. 1A). Aged Plan muscle mass was not affected by
functional overload or nandrolone decanoate treatments (Fig.
1B). Muscle-to-body weight ratio (mg/kg) data showed a
similar trend as muscle weight. Aged Sol muscle from rats
receiving nandrolone decanoate and functional overload treatments
increased muscle-to-body weight ratio by 39% (P < 0.0001; Table 1). Functional overload and
nandrolone treatment had no effect on Sol protein concentration
(µg/mg) regardless of age (Table 1). However, across both ND and oil
treatment, functional overload significantly decreased adult (157 ± 12 vs. 110 ± 12 µg/mg; P = 0.01) and aged
(157 ± 5 vs. 132 ± 5 µg/mg; P = 0.002) Plan protein concentration (Table 2).
Aged overloaded Sol muscle receiving nandrolone decanoate injections
increased total protein by 25% (28,805 ± 1,069 vs. 35,977 ± 1,872 µg; P = 0.0018). Neither nandrolone
decanoate nor functional overload treatments had an effect on Plan
total muscle protein, regardless of age.
|
|
|
Muscle DNA and RNA concentration.
Muscle DNA content is directly related to the number of nuclei in the
muscle (21). Nuclei may be associated with myofibers, as
well as other cell types within the muscle. The response of DNA content
to functional overload and nandrolone decanoate treatment differed
between the Sol and Plan muscles. Nandrolone decanoate treatment
increased aged Sol muscle DNA concentration (1.42 ± 0.14 vs.
1.87 ± 0.15 µg/mg; P = 0.038; Fig.
2). However, functional overload and
nandrolone decanoate treatment had no effect (1.71 ± 0.15 vs. 1.85 ± 0.15 µg/mg) on adult Sol muscle DNA concentration (1.75 ± 0.15 vs.
1.81 ± 0.15 µg/mg). Interestingly, functional overload significantly
decreased Plan muscle DNA concentration (1.39 ± 0.13 vs. 0.85 ± 0.12 µg/mg; P = 0.01) in aged animals. Functional overload and
nandrolone decanoate treatment had no effect (1.04 ± 0.13 vs.
0.87 ± 0.13 µg/mg) on adult Plan DNA concentration (0.99 ± 0.13 vs. 0.92 ± 0.13 µg/mg). Total RNA
concentration is an indicator of protein synthetic capacity because the
majority of RNA is ribosomal (22). Nandrolone decanoate
treatment had no effect on Sol and Plan RNA concentration (µg/mg) in
both age groups. However, functional overload significantly induced the Sol and Plan RNA concentration (µg/mg) in both ages as averaged across nandrolone decanoate and oil treatment (P < 0.05; Fig. 2).
|
|
Steroid receptor concentration.
The expression of androgen receptor and glucocorticoid receptor protein
in response to functional overload and nandrolone decanoate treatment
differed between the Plan and Sol muscle. Across both nandrolone
decanoate and oil treatments, adult animals subjected to functional
overload increased Sol androgen receptor protein concentration by 113%
(P = 0.001; Fig.
4B). Nandrolone decanoate
treatment had no effect on adult Sol androgen receptor protein
concentration (Fig. 4B). In aged animals, functional
overload and nandrolone decanoate treatments had significant effects
(P < 0.001) on Sol androgen receptor protein
concentration as averaged across treatment group (Fig. 4B).
Aged Sol muscle functionally overloaded and receiving nandrolone
decanoate treatment increased androgen receptor protein concentration
by 27-fold above the aged controls. When nandrolone decanoate and
functional overload treatments were combined, adult Plan androgen
receptor concentration increased threefold greater than the increase
observed with nandrolone decanoate treatment alone (Fig.
4C). Adult Plan muscle, functionally overloaded and
receiving nandrolone decanoate treatment, increased androgen receptor
protein concentration ninefold compared with the adult controls. In the
aged Plan muscle functional overload as averaged across nandrolone
decanoate and oil treatment significantly increased androgen receptor
protein concentration 145% (P = 0.0006; Fig. 4C).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Anabolic steroid administration and functional overload interactions have not been previously examined in aged rat hindlimb muscle. This study's primary finding is that aged animals subjected to 3 wk of nandrolone decanoate pretreatment before 7 days of functional overload increased Sol muscle mass and protein content, whereas aged animals receiving placebo did not. This anabolic steroid and functional overload interaction appears to be phenotype specific because Plan muscle mass did not change in aged animals after functional overload regardless of nandrolone decanoate treatment. Another important finding resulting from this study is that the combination of functional overload and nandrolone decanoate pretreatment induces androgen receptor concentration in aged rat Sol muscle above either treatment alone but that it has no effect on the Plan muscle.
In the rat hindlimb, the examination of the Sol, primarily a slow-type postural muscle, and the Plan, primarily a fast-type muscle, allows comparisons between ankle plantar flexors that are primarily different phenotypes. Understanding the response of primarily fast and slow muscle phenotypes to aging and overload are important endeavors because human muscle is a heterogeneous mix of slow and fast fibers, and fiber-type composition has been shown to be altered with advancing age (31). Both the Sol and Plan muscles respond to functional overload with a rapid and large increase in muscle mass, which consists mainly of enlarged muscle fiber cross-sectional area (28, 45). However, rat hindlimb muscle's capacity to enlarge in response to functional overload is compromised by advancing age (5). The Plan muscle from very aged male Fischer 344 × Brown Norway rats does not undergo hypertrophy after 8 wk of functional overload (5). The present study adds to this previous observation in several ways. The age-induced deficit in skeletal muscle adaptation to functional overload can occur at a considerably younger age, 25 vs. 36 mo. The present study also demonstrates that both primarily fast and slow muscle phenotypes have an attenuated response to functional overload, and this difference can be seen after only 1 wk of functional overload. However, the first week of functional overload includes a large regenerative response in fast- and slow-type rat skeletal muscle that is characterized by edema, macrophage infiltration, connective tissue proliferation, and satellite cell proliferation (28). Because of the lack of protein accretion at 7 days of overload in all treatment groups except the aged Sol receiving anabolic steroid, the lack of aged Sol and Plan muscle mass induction after 7 days of overload may be related to an altered damage and/or inflammation response. Sol and Plan muscle appear to respond differently to 1 wk of functional overload. Regardless of age, functional overload increased the ratio of RNA to DNA in the Plan muscle but not in the Sol muscle. This muscle-type difference appears to be due more to alterations in the muscle DNA pool with overload, rather differential induction of total RNA. Microarray analysis of gene expression in 3-day functionally overloaded Sol muscle from young rats has identified 112 differentially expressed genes compared with the control, and this list includes many local inflammation markers (13). Age-related alterations in skeletal muscle regenerative capacity are a promising candidate for rat hindlimb muscle's attenuated plasticity at the onset of functional overload. Advancing age can diminish skeletal muscle's regenerative response to stimuli producing muscle damage (8, 22, 28, 30).
A strong and growing body of scientific evidence suggests that
age-induced decrements in muscle regenerative capacity are not
intrinsic to the muscle but are dependent on the aging organism as a
whole (9, 22). Systemic changes with aging that have implications for skeletal muscle regeneration include the
cardiovascular, immune, and endocrine systems (31).
Alterations in the endocrine system with age, including decreased
testosterone levels and altered growth hormone release, continue to be
targets of antiaging therapies (21, 31, 47). The numerous
biological targets of anabolic steroids, synthetic derivatives of
testosterone, limit their therapeutic use in aged individuals
(21, 47). The regulation of skeletal muscle mass by
anabolic steroid-induced cellular signaling and the potential for
interactions with mechanical signaling pathways have not been well
defined. Studies examining exogenous testosterone administration's
effect on young rat skeletal muscle mass have reported mixed results,
and even less is understood about targets of altered gene expression
(1, 7, 45, 48). Differences in results between studies are
likely due to drug type, dosage, and administration schedules.
Nandrolone decanoate, used in the present study, is known to have a
greater proportional effect in tissues with low
5-reductase activity such as the muscle, compared with
tissues with high
5-reductase activity, such as prostate
(2). However, the nandrolone decanoate administration used
in the presentstudy did significantly increase rat prostate weight in
the aged rats but not in the 5-mo-old animals (12). An
interactive effect on muscle mass has been shown between anabolic steroid administration and mechanical overload in both
resistance-trained humans and rat skeletal muscle subject to disuse
atrophy (45). The present study also finds an interaction
between muscle loading and anabolic steroid administration; however,
this interaction was dependent on both the age of the animal and the
primary muscle phenotype. No anabolic steroid and overload interactions
were present on muscle mass and protein content in the young Sol
muscle. The RNA-to-DNA ratio responded differently to nandrolone
decanoate treatment in the Plan and Sol muscle. Only the aged Sol
RNA-to-DNA ratio was significantly reduced by nandrolone decanoate
treatment, which appears to be mainly due to an increase in the muscle
DNA pool. Regardless of age, Plan muscle mass or protein content did not respond to anabolic steroid administration with or without functional overload, which is in agreement with the findings of others
(36, 45). Several variables appear to modulate anabolic steroid action on skeletal muscle, including animal gender, animal age,
primary muscle phenotype, anabolic steroid type, and anabolic steroid
dosage. All of these variables are critical and must be accounted for
when examining anabolic steroid administration's effect on skeletal muscle.
The androgen receptor and associated signaling pathways that modulate its biological actions are excellent candidates for regulating gene expression that influences skeletal muscle mass. However, signaling pathways related to androgen receptor action during functional overload-induced muscle growth are not well described. Because steroid hormone actions are mediated by their cognate receptors, receptor abundance can influence the steroid-mediated response within a cell (44). Androgen receptor expression in skeletal muscle is sensitive to muscle growth-promoting stimuli. The androgen receptor ligand binding capacity increases in functionally overloaded rat skeletal muscle (6, 23). Our data demonstrate that this increase in ligand binding is in part due to an induction of androgen receptor protein level after 7 days of functional overload. Intense exercise can induce transient elevation of circulating testosterone level in humans, and corresponding increases in skeletal muscle androgen receptor binding (43). Increased androgen receptor abundance could serve to increase the muscles' sensitivity to androgens. Androgen receptor induction may play an important role in overload-induced growth, because inhibition of androgen receptor action can partially attenuate overload-induced muscle growth in rats (26). However, the present data also support the hypothesis that androgen receptor induction is not sufficient for inducing muscle growth. Overload or nandrolone decanoate treatments induced androgen receptor protein concentration in the absence of any significant change in muscle mass. Exogenous testosterone administration has also been shown to increase androgen receptor protein concentration (18, 39). However, the present study extends these observations by demonstrating an interaction between overload and nandrolone decanoate treatment on androgen receptor protein induction. The combination of nandrolone decanoate and functional overload resulted in a 27-fold induction of androgen receptor protein concentration. This large induction of androgen receptor protein in the aged Sol by the combination of overload and steroid treatments may be important for the corresponding increase in muscle mass. The aged Plan did not increase muscle mass in response to nandrolone decanoate administration and overload, and there was also no corresponding increase in androgen receptor protein with both treatments as in the aged Sol.
Androgen receptor protein induction could reside in either myofibers and/or activated satellite cells within the aged Sol muscle. Satellite cells, quiescent myoblasts residing between the basil lamina and the muscle fiber sarcolemma, are the source of nuclei for growing and regenerating muscle fibers (37). Aging can alter the proliferation potential and number of satellite cells in rat muscle (21, 40). Decreased IGF-I induction in the aged rat may decrease satellite cell proliferation and subsequent fusion (22, 46). Androgens directly target satellite cells and can increase satellite cell activation and myonuclei accumulation in the rat levator ani muscle (27). Nandrolone decanoate administration alone can increase aged Sol total DNA content (12), which could represent an altered nuclei to cytoplasm ratio due to increased satellite cell proliferation. In the present study, anabolic steroid administration in combination with functional overload increased aged Sol DNA concentration, leaving the possibility that at least a portion of the androgen receptor induction may be in proliferating and/or differentiating satellite cells. However, androgen receptor protein was not quantified until day 7 of functional overload, and satellite cell proliferation would have been occurring at much earlier time points. Further work will be needed to better associate androgen receptor induction with satellite cell differentiation.
Glucocorticoid action is associated with cellular catabolism, and elevated levels of circulating glucocorticoids can result in muscle atrophy (23). However, resistance exercise and functional overload can prevent glucocorticoid-induced muscle atrophy (24). It has been hypothesized that supraphysiological doses of anabolic steroids may act on skeletal muscle by androgen receptor-independent mechanism, such as interaction with glucocorticoid receptors (17, 24). Anabolic steroid interaction with the glucocorticoid receptor could prevent glucocorticoid binding, providing a stimulus for androgen-induced muscle hypertrophy (32). However, there are several confounding variables associated with this hypothesis. Anabolic steroids have low binding affinity for the glucocorticoid receptor (24), and glucocorticoid receptor protein concentration significantly increases in the functionally overloaded Plan muscle. Glucocorticoid receptor binding capacity is not affected by either castration or androgen treatment (42), and this suggests that anabolic steroids do not participate in hypertrophy-induced glucocorticoid receptor proliferation. The present study demonstrates that Plan muscle glucocorticoid receptor concentration is induced by functional overload in adult animals. Our data suggest that glucocorticoid receptor levels do not appear to be as sensitive to circulating androgen levels as the androgen receptor protein, because anabolic steroid administration had no effect on glucocorticoid receptor expression in either the Sol or Plan muscle. However, in the present study, anabolic steroid administration increased androgen receptor abundance in both the Sol and Plan muscles, thus increasing the number of androgen-specific receptors. The relationship of glucocorticoid receptor induction by functional overload and increased muscle mass is also not certain, because aged Sol increased glucocorticoid concentration without increasing muscle mass.
In summary, aged Fischer 344 × Brown Norway rats can increase Sol muscle mass and total protein content with the combination of 7 days of functional overload and nandrolone decanoate treatment. In aged animals, neither functional overload nor ND treatment alone induced the wet muscle weight and total protein content of either the Sol or Plan muscles. Androgen receptor expression was synergistically induced by the combination of functional overload and nandrolone decanoate treatments in the aged rat Sol but not in the Plan. Nandrolone decanoate treatment had no effect of glucocorticoid receptor expression Sol or Plan muscles from aged animals. These data demonstrate that both animal age and muscle phenotype have an effect on nandrolone decanoate interaction with functional overload. The androgen receptor and associated signaling pathways remain an excellent candidate for mediating this interaction during muscle regeneration and subsequent growth.
| |
ACKNOWLEDGEMENTS |
|---|
The authors acknowledge the technical assistance of Tyrone Washington and Ray Thompson.
| |
FOOTNOTES |
|---|
This work was funded by a grant from the American Federation for Aging Research.
Address for reprint requests and other correspondence: J. A. Carson, Univ. of South Carolina, Dept. of Exercise Science, 1300 Wheat St., Columbia, SC 29208 (E-mail: carsonj{at}sc.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
10.1152/japplphysiol.00822.2002
Received 10 September 2002; accepted in final form 27 October 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Antonio, J,
Wilson JD,
and
George FW.
Effects of castration and androgen treatment on androgen receptor levels in rat skeletal muscle.
J Appl Physiol
87:
2016-2019,
1999
2.
Bergink, EW,
Janssen PS,
Turpijin EW,
and
van der Vies J.
Comparison of the receptor binding properties of nandrolone and testosterone under in vitro and in vivo conditions.
J Steroid Biochem
22:
831-836,
1985[ISI][Medline].
3.
Bhasin, S,
Storer TW,
Berman N,
Callegari C,
Clevenger B,
Phillips J,
Bunnell TJ,
Tricker R,
Shirazi A,
and
Casaburi R.
The effects of supraphysiological doses of testosterone on muscle size and strength in normal men.
N Engl J Med
335:
1-7,
1996
4.
Bhasin, S,
Storer TW,
Berman N,
Yarasheski KE,
Clevenger B,
Phillips J,
Lee PW,
Bunnell TJ,
and
Casaburin R.
Testosterone replacement increases fat-free mass and muscle size in hypogonadal men.
J Clin Endocrinol Metab
82:
407-413,
1997
5.
Blough, ER,
and
Linderman JK.
Lack of skeletal muscle hypertrophy in very aged male Fischer 344 × Brown Norway Rats.
J Appl Physiol
88:
1265-1270,
2000
6.
Boissonneault, G,
Gagnon J,
Ho-Kim MA,
and
Tramblay RR.
Lack of effect of anabolic steroids on specific mRNAs of skeletal muscle undergoing compensatory hypertrophy.
Mol Cell Endocrinol
51:
19-24,
1987[ISI][Medline].
7.
Bricout, VA,
Serrurier BD,
Bigard AX,
and
Guezennec CY.
Effects of hindlimb suspension and androgen treatment on testosterone receptors in rat skeletal muscle.
Eur J Appl Physiol
79:
443-448,
1999.
8.
Brooks, SV,
and
Faulkner JA.
Contraction-induced injury: recovery of skeletal muscles in young and old mice.
Am J Physiol Cell Physiol
258:
C436-C444,
1990
9.
Carlson, BM,
Dedkov EI,
Borisov AB,
and
Faulkner JA.
Skeletal muscle regeneration in very old rats.
J Gerontol A Biol Sci Med Sci
56:
B224-B233,
2001
10.
Carson, JA,
and
Alway SE.
Stretch overload-induced satellite cell activation in slow tonic muscle from adult and aged Japanese quail.
Am J Physiol Cell Physiol
270:
C578-C584,
1996
11.
Carson, JA,
and
Booth FW.
Effect of serum and mechanical stretch on skeletal alpha-actin gene regulation in cultured primary muscle cells.
Am J Physiol Cell Physiol
275:
C1438-C1448,
1998
12.
Carson, JA,
Lee WJ,
McClung J,
and
Hand GA.
Steroid receptor concentration in aged rat hindlimb muscle: effect of anabolic steroid administration.
J Appl Physiol
93:
242-250,
2002
13.
Carson, JA,
Nettleton D,
and
Reecy JM.
Differential gene expression in the rat soleus muscle during early work overload-induced hypertrophy.
FASEB J
16:
207-209,
2002
14.
Carson, JA,
Yamaguchi M,
and
Always SE.
Hypertrophy and fiber proliferation of skeletal muscle fibers from aged quail.
J Appl Physiol
78:
293-299,
1995
15.
Catudioc-Vallero, J,
Sands JM,
Klein JD,
Sidorowicz HE,
and
Sladek CD.
Effect of age and testosterone on the vasopressin and aquaporin responses to dehydration in Fischer 344/Brown-Norway F1 rats.
J Gerontol A Biol Sci Med Sci
55:
B26-B34,
2000[Abstract].
16.
Dangott, B,
Schultz E,
and
Mozdziak PE.
Dietary creatine monohydrate supplementation increases satellite cell mitotic activity during compensatory hypertrophy.
Int J Sports Med
21:
13-16,
2000[ISI][Medline].
17.
Danhaive, PA,
and
Rousseau GG.
Evidence for sex-dependent anabolic response to androgenic steroids mediated by muscle glucocorticoid receptors in rat.
J Steroid Biochem
29:
575-581,
1988[ISI][Medline].
18.
Ferrando, AA,
Sheffield-Moore M,
Yeckel CW,
Gilkison C,
Jiang J,
Achacosa A,
Lieberman SA,
Tipton K,
Wolfe RR,
and
Urban RJ.
Testosterone administration to older men improves muscle function: molecular and physiological mechanisms.
Am J Physiol Endocrinol Metab
282:
E601-E607,
2002
19.
Fluck, M,
Carson JA,
Gordan SE,
Ziemiecki A,
and
Booth FW.
Focal adhesion proteins FAK and paxillin increase in hypertrophied skeletal muscle.
Am J Physiol Cell Physiol
277:
C152-C162,
1999
20.
Fluck, M,
Carson JA,
Schwartz RJ,
and
Booth FW.
SRF protein is upregulated during stretch-induced hypertrophy of rooster ALD muscle.
J Appl Physiol
86:
1793-1799,
1999
21.
Gibson, MC,
and
Shultz E.
Age-related differences in absolute numbers of skeletal muscle satellite cells.
Muscle Nerve
6:
574-580,
1983[ISI][Medline].
22.
Grounds, MD.
Age associated changes in the response of skeletal muscle cells to exercise and regeneration.
Ann NY Acad Sci
854:
78-91,
1998
23.
Hickson, RC,
Kurowski TT,
Galassi TM,
Danniels DG,
and
Chatterton RJ.
Androgen cytosol binding during compensatory overload-induced skeletal muscle hypertrophy.
Can J Biochem Cell Biol
63:
348-354,
1985[ISI][Medline].
24.
Hickson, RC,
Czerwinski SM,
Falduto MT,
and
Young AP.
Glucocorticoid antagonism by exercise and androgenic-anabolic steroids.
Med Sci Sports Exerc
22:
331-340,
1990[ISI][Medline].
25.
Huang, ZQ,
and
Wong J.
AR possesses an intrinsic hormone-independent transcriptional activity.
Mol Endocrinol
16:
924-937,
2002
26.
Inoue, K,
Yamasaki S,
Fushiki T,
Okada Y,
and
Sugimoto E.
Androgen receptor antagonist suppresses exercise-induced hypertrophy of skeletal muscle.
Eur J Appl Physiol
69:
88-91,
1994.
27.
Joubert, Y,
and
Tobin C.
Testosterone treatment results in quiescent satellite cells being activated and recruited into cell cycle in rat levator ani muscle.
Dev Biol
169:
286-294,
1995[ISI][Medline].
28.
Kelso, TB,
Shear CR,
and
Max SR.
Enzymes of glutamine metabolism in inflammation associated with skeletal muscle hypertrophy.
Am J Physiol Endocrinol Metab
257:
E885-E894,
1989
29.
Lee, CK,
Klopp RG,
Weindruch R,
and
Prolla TA.
Gene expression profile of aging and its retardation by caloric restriction.
Science
285:
1390-1393,
1999
30.
Marsh, DR,
Criswell DS,
Carson JA,
and
Booth FW.
Myogenic regulatory factors during regeneration of skeletal muscle in young, adult, and old rats.
J Appl Physiol
83:
1270-1275,
1997
31.
Masoro, EJ.
(Editor).
Handbook of Physiology. Aging. Bethesda, MD: Am. Physiol. Soc, 1995, p. 413-591, sect. 11.
32.
Mayer, M,
and
Rosen F.
Interaction of anabolic steroids with glucocorticoid receptor sites in rat muscle cytosol.
Am J Physiol
229:
1381-1386,
1975
33.
McKenna, NJ,
Lanz RB,
and
O'Malley BW.
Nuclear receptor coregulators: cellular and molecular biology.
Endocr Rev
20:
321-344,
1999
34.
Owino, V,
Yang SY,
and
Goldspink G.
Age-related loss of skeletal muscle function and the inability to express the autocrine form of insulin-like growth factor-1 (MGF) in response to mechanical overload.
FEBS Lett
505:
259-263,
2001[ISI][Medline].
35.
Proctor, DN,
Balagopal P,
and
Nair KS.
Age-related sacopenia in humans is associated with reduced synthetic rates of specific muscle proteins.
J Nutr
128:
351S-355S,
1998
36.
Rance, NE,
and
Max SR.
Modulation of the cytosolic androgen receptor in striated muscle by sex steroids.
Endocrinology
115:
862-866,
1984[Abstract].
37.
Rosenblatt, JD,
and
Parry DJ.
Gamma irradiation prevents compensatory hypertrophy of overloaded mouse extensor digitorum longus muscle.
J Appl Physiol
73:
2538-2543,
1995
38.
Sih, R,
Morley JE,
Kaiser FE,
Perry HM, 3rd,
Patrick P,
and
Ross C.
Testosterone replacement in older hypogonadal men: a 12-month randomized control trial.
J Clin Endocrinol Metab
82:
1661-1667,
1997
39.
Sheffield-Moore, M,
Urban RJ,
Wolf SE,
Jiang J,
Catlin DH,
Herndon DN,
Wolfe RR,
and
Ferrando AA.
Short-term oxandrolone administration stimulates net protein synthesis in young men.
J Clin Endocrinol Metab
84:
2705-2711,
1999
40.
Shultz, E,
and
Lipton BH.
Skeletal muscle satellite cells: changes in proliferation potential as a function of age.
Mech Ageing Dev
20:
377-383,
1982[ISI][Medline].
41.
Snow, MH.
Satellite cell response in rat soleus muscle undergoing hypertrophy due to surgical ablation of synergists.
Anat Rec
227:
437-446,
1990[Medline].
42.
Tanaka, H,
Gibb W,
Ducharme JR,
and
Collu R.
Influence of compensatory overload on glucocorticoid receptors in rat skeletal muscle.
Steroids
51:
115-122,
1988[Medline].
43.
Tchaikovsky, VS,
Astratenkova JV,
and
Basharina OB.
The effect of exercises on the content and reception of the steroid hormones in rat skeletal muscles.
J Steroid Biochem
24:
251-253,
1986[ISI][Medline].
44.
Tsai, J,
and
O'Malley BW.
Molecular mechanisms of action of steroid/thyroid receptor superfamily members.
Annu Rev Biochem
63:
451-486,
1994[ISI][Medline].
45.
Tsika, RW,
Herrick RE,
and
Bladwin KM.
Effect of anabolic steroids on skeletal muscle mass during hindlimb suspension.
J Appl Physiol
63:
2122-2127,
1987
46.
Ullman, M,
Ullman A,
Sommerland H,
Skottner A,
and
Oldfors A.
Effects of growth hormone on muscle regeneration and IGF-I concentration in old rats.
Acta Physiol Scand
140:
521-525,
1990[ISI][Medline].
47.
Urban, RJ,
Boldenburg YH,
Gilkison C,
Foxworth J,
Coggan AR,
Wolfe RR,
and
Ferrando A.
Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis.
Am J Physiol Endocrinol Metab
269:
E820-E826,
1995
48.
Wimalawansa, SM,
Chapa MT,
Wei JN,
Westlund KN,
Quast MJ,
and
Wimalwansa SJ.
Reversal of weightlessness-induced musculoskeletal losses with androgens: quantification by MRI.
J Appl Physiol
86:
1841-1846,
1999
This article has been cited by other articles:
![]() |
J. M. McClung, K. A. Mehl, R. W. Thompson, L. L. Lowe, and J. A. Carson Nandrolone decanoate modulates cell cycle regulation in functionally overloaded rat soleus muscle Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1543 - R1552. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Lee, R. W. Thompson, J. M. McClung, and J. A. Carson Regulation of androgen receptor expression at the onset of functional overload in rat plantaris muscle Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R1076 - R1085. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |